SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community debates the impact of potential market manipulation and government actions, including tariff announcements, on the recent price drop. Some traders believe that a coordinated effort by institutional investors caused a massive liquidation event, while others view the dip as a buying opportunity before a year-end rally. Discussions also involve Bitcoin's role as a safe haven asset amid broader economic uncertainty.

Real Asian Hours

The "CHINAWINS" crypto token is gaining traction, seemingly fueled by community enthusiasm around its name and perceived connection to success. Social media buzz suggests users are actively loading up on the token via Phantom Wallet, with some drawing comparisons to other cryptocurrencies like $BTC and $SOL. The community narrative centers on a "we win" mentality and the idea of immediate action.

Floki Cat

Floki Cat ($FCAT) is gaining attention, particularly among users of Phantom Wallet, with community members highlighting its trending status and potential for a price surge. The coin is associated with the Solana blockchain, and discussions often include other meme coins like $PEPE, $UPDOG, and $POPCAT. Community sentiment suggests growing excitement around $FCAT's momentum.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending amidst discussions around its financial health and potential connections to recent issues in the auto loan market, including bankruptcies and concerns over subprime lending practices. The community is actively debating the company's accounting methods, insider selling, and the sustainability of its business model in light of broader economic challenges. Analyst ratings are being scrutinized alongside reports of investigations, creating a volatile environment for the stock.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as investors weigh its correlation to Bitcoin's price movements amidst a volatile crypto market, with some community members expressing concern over potential losses. Discussion revolves around Strategy's leveraged position in Bitcoin and whether it will outperform Bitcoin itself. Some traders are considering options strategies and keeping an eye on technical indicators for potential entry points.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Grayscale Ethereum Mini Trust is trending as Ethereum experiences volatility amidst broader market discussions on potential rate cuts and ETF inflows. Community members are actively debating its future price, with some highlighting its potential to outperform Bitcoin due to institutional interest and its role in tokenization. Talk surrounds Grayscale staking more ETH, and discussion of a potential rally.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amidst a broader crypto market downturn, with the community actively discussing potential buying opportunities and the impact of market liquidations. Chatter includes speculation about orchestrated market movements and the resilience of certain Solana-based tokens. Additionally, some users are highlighting specific Solana meme tokens and projects, indicating interest in the Solana ecosystem.

Zoracles

Zoracles ($ZORA) is trending as the community discusses its recent listing on Robinhood and potential for growth as a social media token. Despite market volatility, some see $ZORA as showing strength, with discussions around its utility for content creators and potential integration with Base. Investors are actively debating entry points and long-term potential, while also cautioning about possible pullbacks.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending due to news of settling litigation and regaining Nasdaq compliance, sparking optimism about the company's future. The community is focused on its low float and potential for a short squeeze, with some drawing comparisons to other high-flying stocks. Bullish sentiment is building around the company's turnaround story and expansion plans in the green infrastructure sector.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as traders assess its recent performance and future potential, with community members pointing to technical indicators and potential support levels. Bullish sentiment is emerging based on the stock closing above key moving averages, while others are watching for short trigger signals. Options activity and potential long-term plays are also being actively discussed.

statis crypto Watchlist

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade

Novavax (NVAX) closed the most recent trading day at $9.08, moving 4.02% from the previous trading session.

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Novavax (NVAX) settling at $8.67, representing a +1.17% change from its previous close.

Novavax, Inc. (NVAX) on Tuesday said that it has amended its collaboration and license agreement with Sanofi (SNY) to include the use of its Matrix-M adjuvant in Sanofi's pandemic influenza vaccine candidate program.The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate. The two players will negotiate license rates and financial terms if the program enters late-stage study, Novavax <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.novavax.com/press-releases/2025-09-30-Novavax-Announces-Progress-on-Sanofi-Agreement">said</a>.Matrix-M is Novavax's proprietary adjuvant that can be added to a vaccine to stimulate a stronger immune response and is currently used in globally approved vaccines. Sanofi is currently exploring additional opportunities with Matrix-M, Novavax said.<a href="https://stocktwits.com/symbol/NVAX">NVAX stock</a> traded 1.4% lower on Tuesday morning and was among the top trending tickers on Stocktwits. On Stocktwits, retail sentiment around NVAX stock stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.A Stocktwits user opined that the agreement is a long-term payout play.<stembedurl>https://stocktwits.com/DifferentRadar/message/630462629</stembedurl>The new amendment adds to the terms of the original agreement between the two companies, dated May 2024. Under the agreement, Novavax is entitled to receive up to $200 million for the first four products created by Sanofi utilizing its Matrix-M adjuvant, and up to $210 million in milestone payments for each product including Matrix-M thereafter. Novavax is also eligible to receive royalties for all Sanofi products utilizing Matrix-M.Sanofi is Novavax’s biggest partner. In the second quarter, the $199 million received from Sanofi accounted for over 83% of Novavax’s total revenue of $239 million.NVAX stock is up by 5% this year but down by 33% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-gets-price-target-hike-from-canaccord/chDD7JrR3Bq">Tesla Gets A Price Target Hike From Canaccord: Retail Sees Stock Touching New Highs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a covid-19 vaccine is seen with the Novavax logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images)

Novavax Amends Deal With Sanofi, Broadens Partnership

The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.

Equity

The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.


Here's Why Novavax (NVAX) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax (NVAX) Declines More Than Market: Some Information for Investors

Novavax (NVAX) concluded the recent trading session at $8.68, signifying a -2.2% move from its prior day's close.

Here's Why Novavax (NVAX) Fell More Than Broader Market

Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the LP.8.1 COVID-19 variant in phase IV study.

COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths

MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

NVAX
Novavax Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NVAX News

NVAXNovavax Inc